AbbVie to buy Pharmacyclics in $21 billion deal
March 04, 2015 at 22:59 PM EST
March 4 (Reuters) - AbbVie Inc said it will buy cancer drug company Pharmacyclics Inc in a $21 billion deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.